Cargando…
Systemic reduced‐dose alteplase for diffuse pulmonary thrombi in a COVID‐19 patient
Pulmonary embolism has a high frequency in COVID‐19 patients admitted to the intensive care unit. Low level of fibrinolysis is one of the asserted contributors to a prothrombotic state in COVID‐19. Thrombotic coagulopathy is mostly encountered as diffuse pulmonary thrombi. Diffuse pulmonary microemb...
Autor principal: | Colkesen, Yucel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017398/ https://www.ncbi.nlm.nih.gov/pubmed/36937632 http://dx.doi.org/10.1002/ccr3.7116 |
Ejemplares similares
-
Retrograde pedal access with a 20-gauge intravenous cannula after failed antegrade recanalization of a tibialis anterior artery in a diabetic patient: a case report
por: Colkesen, Yucel
Publicado: (2015) -
Moxifloxacin Monotherapy in Left-Sided Staphylococcus aureus Endocarditis
por: Colkesen, Yucel
Publicado: (2021) -
Half-dose thrombolytic therapy in patients with right heart
thrombi
por: Moosavi, Jamal, et al.
Publicado: (2019) -
Use of carefully titrated ultra‐low doses of alteplase in infected haemothorax caused by initial alteplase use to drain loculated malignant pleural effusion
por: Oh, Jeong Suk, et al.
Publicado: (2023) -
Biventricular Thrombi Associated With Myocardial Infarction in a Patient With COVID-19
por: Soltani, Marwa, et al.
Publicado: (2020)